Everolimus in postmenopausal, hormone receptor-positive advanced breast cancer: summary and results of an austrian expert panel discussion. Veröffentlicht vonadmin 27. Juli 2020 Gnant M, Greil R, Hubalek M, Steger G. http://www.ncbi.nlm.nih.gov/pubmed/24415983